Bispecific Antibodies Are Redefining Cancer TherapyBy Press Room18 September 2025 In less than a decade, bispecific antibodies have gone from scientific curiosity to frontline cancer therapeutics. These engineered proteins, capable…
How 1301B7 Could Contribute To Advanced Vaccine DevelopmentBy Press Room7 June 2024 In the ongoing Omicron era, a new COVID-19 antibody could renew optimism for urgently required SARS-CoV-2 monoclonal therapies. Over the…